Diabetic neuropathy.
Diabetic neuropathy.
复制标题
DOI：
10.1016/b978-0-7020-4087-0.00051-6
复制
发表时间：
2014-01-01
影响因子：
--
通讯作者：
Lopez, Norma
中科院分区：
文献类型：
--
作者：
Charnogursky, Gerald;Lee, Hong;Lopez, Norma
与糖尿病相关的神经病变可影响60-70%的糖尿病患者。这些可以包括外周多发性神经病、单神经病和自主神经病。控制血糖、血脂和高血压以及戒烟可以限制这些神经病变的发作和进展。除了控制上述风险因素外，我们还没有有效的药物来治疗糖尿病神经病变的病理生理机制。治疗仅限于改善疼痛和纠正神经病理过程的终末器官后果。
Neuropathies related to diabetes mellitus can affect 60-70% of patients with diabetes. These can include peripheral polyneuropathies, mononeuropathies, and autonomic neuropathies. Control of glucose, lipids, and hypertension and cessation of smoking can limit onset and progression of these neuropathies. Besides control of the above listed risk factors, we do not have effective medications to treat the pathophysiologic mechanisms of diabetic neuropathies. Treatment is limited to ameliorating pain and correcting the end organ consequences of the neuropathic processes.